tm logo

Monitor this mark

View On USPTO

AMNIOFIX
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 13 Jul 2024

Last Applicant/ Owned by

MiMedx Group, Inc.

1775 West Oak Commons Ct. NE

Marietta

GA

30062

Serial Number

87580508 filed on 23rd Aug 2017

Registration Number

5407621 registered on 20th Feb 2018

in the Principal Register

Correspondent Address

Marcy Sperry

Marcy Sperry Sperry IP Law LLC dba Vivid IP

Atlanta, GA 30305

United States

Filing Basis

1. filed as use application

2. use application currently

Disclaimer

NO DATA

AMNIOFIX

biologic drugs for treating inflammation and pain using regenerative tissue components

Classification Information

Class [005]
Pharmaceutical Products

biologic drugs for treating inflammation and pain using regenerative tissue components

First Use Date in General

30th Sep 2011

First Use Date in Commerce

30th Sep 2011

Specimens

AMNIOFIX specimenAMNIOFIX specimen

Mark Details

Serial Number

No 87580508

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
13th Jul 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
13th Jul 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
13th Jul 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02th Jan 2024TEAS SECTION 8 & 15 RECEIVED
20th Feb 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
15th Jul 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03rd Apr 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03rd Apr 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
03rd Apr 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03rd Apr 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED